Because these medications do not stay in the blood in a way that is known to harm a recipient, and because the conditions they treat (like Type 2 diabetes or obesity) do not automatically disqualify a person, they are generally considered safe for donors
6 The future and prospects of PYY 6.1 Potential of PYY as a therapeutic target The clinical application of PYY(336) is limited by its short halflife and dosedependent side effects such as nausea and vomiting (156)
Similarly, oral formulations such as orforglipron show high potential for improving adherence, but their safety in humans remains under monitoring (Wharton et al., 2025)
Some GPs are receiving specialist training to be able to prescribe Wegovy
When stomach emptying slows too much or persists beyond the adjustment period, it can lead to gastroparesis symptoms like nausea, vomiting, bloating, and early fullness